Reaction Details |
| Report a problem with these data |
Target | Nuclear receptor subfamily 5 group A member 2 |
---|
Ligand | BDBM65445 |
---|
Substrate/Competitor | n/a |
---|
IC50 | >35874±n/a nM |
---|
Citation | PubChem, PC Luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) PubChem Bioassay(2013)[AID] |
---|
More Info.: | Get all data from this article |
---|
|
Nuclear receptor subfamily 5 group A member 2 |
---|
Name: | Nuclear receptor subfamily 5 group A member 2 |
Synonyms: | Alpha-1-fetoprotein transcription factor | B1-binding factor | B1F | CPF | CYP7A promoter-binding factor | FTF | Hepatocytic transcription factor | LRH-1 | Liver Receptor Homolog 1 | NR5A2 | NR5A2_HUMAN | Nuclear receptor subfamily 5 group A member 2 | hB1F | nuclear receptor subfamily 5 group A member 2 isoform 2 |
Type: | Nuclear Hormone Receptor |
Mol. Mass.: | 61341.37 |
Organism: | Homo sapiens (Human) |
Description: | n/a |
Residue: | 541 |
Sequence: | MSSNSDTGDLQESLKHGLTPIGAGLPDRHGSPIPARGRLVMLPKVETEALGLARSHGEQG
QMPENMQVSQFKMVNYSYDEDLEELCPVCGDKVSGYHYGLLTCESCKGFFKRTVQNNKRY
TCIENQNCQIDKTQRKRCPYCRFQKCLSVGMKLEAVRADRMRGGRNKFGPMYKRDRALKQ
QKKALIRANGLKLEAMSQVIQAMPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPF
VTSPISMTMPPHGSLQGYQTYGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPAS
IPHLILELLKCEPDEPQVQAKIMAYLQQEQANRSKHEKLSTFGLMCKMADQTLFSIVEWA
RSSIFFRELKVDDQMKLLQNCWSELLILDHIYRQVVHGKEGSIFLVTGQQVDYSIIASQA
GATLNNLMSHAQELVAKLRSLQFDQREFVCLKFLVLFSLDVKNLENFQLVEGVQEQVNAA
LLDYTMCNYPQQTEKFGQLLLRLPEIRAISMQAEEYLYYKHLNGDVPYNNLLIEMLHAKR
A
|
|
|
BDBM65445 |
---|
n/a |
---|
Name | BDBM65445 |
Synonyms: | 3-(2,3-dihydro-1,4-benzodioxin-6-ylamino)-6-(phenylmethyl)-2H-1,2,4-triazin-5-one | 6-benzyl-3-(2,3-dihydro-1,4-benzodioxin-6-ylamino)-1,2,4-triazin-5(4H)-one | 6-benzyl-3-(2,3-dihydro-1,4-benzodioxin-6-ylamino)-2H-1,2,4-triazin-5-one | MLS000675077 | SMR000313799 | cid_2153943 |
Type | Small organic molecule |
Emp. Form. | C18H16N4O3 |
Mol. Mass. | 336.3446 |
SMILES | O=c1[nH]c(Nc2ccc3OCCOc3c2)nnc1Cc1ccccc1 |
Structure |
|